UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: Factors affecting uptake

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 1, 2015, Pages 67-73

  Gil, M M ^a   Giunta, G ^a   Macalli, E A ^a   Poon, L C ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cell free dna; Chorionic villus sampling; Decision making; First trimester; First trimester screening; Prenatal diagnosis

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; BLOOD; CELL FREE SYSTEM; CHORION VILLUS SAMPLING; CLINICAL TRIAL; DECISION MAKING; EPIDEMIOLOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; HUMAN; MALE; MATERNAL AGE; METABOLISM; MULTICENTER STUDY; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT ATTITUDE; PILOT STUDY; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRISOMY; UNITED KINGDOM;

ADULT; CELL-FREE SYSTEM; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI SAMPLING; DECISION MAKING; DNA; FEMALE; GENETIC COUNSELING; GREAT BRITAIN; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TRISOMY;

EID: 84920848932     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14683     Document Type: Article

References (24)

1. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011; 31: 7-15.
2. Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther 2014; 35: 118-126.
3. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014; 35: 156-173.
4. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e1-6.
5. Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013; 42: 34-40.
6. Quezada MS, Gil MM, Francisco C, Oròsz G, Nicolaides KH. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol 2015; 45: 36-41.
7. Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013; 42: 41-50.
8. Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther 2014; 35: 185-192.
9. Wright D, Wright A, Nicolaides KH. A unified approach to risk assessment for fetal trisomies. Ultrasound Obstet Gynecol 2015; 45: 48-54.
10. Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183-196.
11. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 319.e1-9.
12. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-5.
13. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 2013; 41: 21-25.
14. Alberman E, Huttly W, Hennessy E, McIntosh A. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome. Prenat Diagn 2003; 23: 801-806.
15. Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005; 193: 322-326.
16. Mueller VM, Huang T, Summers AM, Winsor SH. The influence of risk estimates obtained from maternal serum screening on amniocentesis rates. Prenat Diagn 2005; 25: 1253-1257.
17. Benn PA, Fang M, Egan JF. Trends in the use of second trimester maternal serum screening from 1991 to 2003. Genet Med 2005; 7: 328-331.
18. Jaques AM, Collins VR, Muggli EE, Amor DJ, Francis I, Sheffield LJ, Halliday JL. Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome. Prenat Diagn 2010; 30: 522-530.
19. Lichtenbelt KD, Schuring-Blom GH, van der Burg N, Page-Christiaens GC, Knoers NV, Schielen PC, Koster MP. Factors determining uptake of invasive testing following first-trimester combined testing. Prenat Diagn 2013; 33: 328-333.
20. Chetty S, Garbedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013; 33: 542-546.
21. Kuppermann M, Gates E, Washington AE. Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socieconomics, or patient knowledge? Obstet Gynecol 1996; 87: 675-682.
22. Kooij L, Tymstra T, Berg PV. The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 2009; 29:164-168.
23. Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011; 31: 1292-1299.
24. Lewis C, Hill M, Silcock C, Daley R, Chitty LS. Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. BJOG 2014; 121: 582-594.